A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with moderate ADHD symptoms

A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with... Eur Child Adolesc Psychiatry (2018) 27:377–384 https://doi.org/10.1007/s00787-017-1058-z ORIGINAL CONTRIBUTION A double‑blind placebo‑controlled randomised trial of omega‑3 supplementation in children with moderate ADHD symptoms 1,2,3,12 4,5,6 1 1 Catherine Cornu  · Catherine Mercier  · Tiphanie Ginhoux  · Sandrine Masson  · 4 2,3 1,2,3 1 7 8 Julie Mouchet  · Patrice Nony  · Behrouz Kassai  · Valérie Laudy  · Patrick Berquin  · Nathalie Franc  · 9 10 11 Marie‑France Le Heuzey  · Hugues Desombre  · Olivier Revol   Received: 14 February 2017 / Accepted: 23 September 2017 / Published online: 5 October 2017 © Springer-Verlag GmbH Germany 2017 Abstract age was 9.90 (SD 2.62) years and 78.4% were boys. The Objective Clinical trials and inconclusive meta-analyses inclusion ADHD-RS-IV at was 37.31 (SD 8.40). The total have investigated the effects of omega-3 supplements in ADHD-RS-IV score reduction was greater in the placebo children with Attention-Deficit Hyperactivity Disorder group than in the DHA–EPA group: −19 (−26, −12)  % and (ADHD). We performed a randomised placebo-controlled −9.7 (−16.6, −2.9) %, respectively, p = 0.039. The other trial to evaluate the efficacy of omega-3 fatty acids. components of the Conners score had a similar variation but Methods Children aged 6–15  years with established the differences between groups were not significant. Two diagnosis of ADHD were randomised 1:1 to receive either patients in the DHA–EPA http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Child & Adolescent Psychiatry Springer Journals
Loading next page...
 
/lp/springer_journal/a-double-blind-placebo-controlled-randomised-trial-of-omega-3-UmxmTPVGi0
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag GmbH Germany
Subject
Medicine & Public Health; Psychiatry
ISSN
1018-8827
eISSN
1435-165X
D.O.I.
10.1007/s00787-017-1058-z
Publisher site
See Article on Publisher Site

Abstract

Eur Child Adolesc Psychiatry (2018) 27:377–384 https://doi.org/10.1007/s00787-017-1058-z ORIGINAL CONTRIBUTION A double‑blind placebo‑controlled randomised trial of omega‑3 supplementation in children with moderate ADHD symptoms 1,2,3,12 4,5,6 1 1 Catherine Cornu  · Catherine Mercier  · Tiphanie Ginhoux  · Sandrine Masson  · 4 2,3 1,2,3 1 7 8 Julie Mouchet  · Patrice Nony  · Behrouz Kassai  · Valérie Laudy  · Patrick Berquin  · Nathalie Franc  · 9 10 11 Marie‑France Le Heuzey  · Hugues Desombre  · Olivier Revol   Received: 14 February 2017 / Accepted: 23 September 2017 / Published online: 5 October 2017 © Springer-Verlag GmbH Germany 2017 Abstract age was 9.90 (SD 2.62) years and 78.4% were boys. The Objective Clinical trials and inconclusive meta-analyses inclusion ADHD-RS-IV at was 37.31 (SD 8.40). The total have investigated the effects of omega-3 supplements in ADHD-RS-IV score reduction was greater in the placebo children with Attention-Deficit Hyperactivity Disorder group than in the DHA–EPA group: −19 (−26, −12)  % and (ADHD). We performed a randomised placebo-controlled −9.7 (−16.6, −2.9) %, respectively, p = 0.039. The other trial to evaluate the efficacy of omega-3 fatty acids. components of the Conners score had a similar variation but Methods Children aged 6–15  years with established the differences between groups were not significant. Two diagnosis of ADHD were randomised 1:1 to receive either patients in the DHA–EPA

Journal

European Child & Adolescent PsychiatrySpringer Journals

Published: Oct 5, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from Google Scholar, PubMed
Create lists to organize your research
Export lists, citations
Read DeepDyve articles
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off